Varian Medical Systems (VAR) 94.60 $VAR Varian Medical

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Varian Medical Systems (VAR) 94.60 $VAR

Varian Medical Systems to Hold Investor Meeting at ASTRO in Boston
PR Newswire - Wed Aug 03, 7:00AM CDT
Varian Medical Systems (NYSE: VAR) will hold a meeting for investors on Tuesday, Sept. 27, 2016, at the annual meeting of the American Society for Radiation Oncology (ASTRO) in Boston.
VAR: 94.60 (+0.14)

Varian Creates Interactive Online Group for Sharing Knowledge-Based RapidPlan Cancer Treatment Models
PR Newswire - Mon Aug 01, 7:15AM CDT
Varian Medical Systems (NYSE: VAR) today announced the creation of an interactive online group in which clinicians can share RapidPlan(TM) models for treating cancer patients using radiotherapy or radiosurgery. Hosted on the OncoPeer(TM) Cloud Community, the RapidPlan Model Sharing group www.oncopeer.com is open to Varian customers, and allows clinicians to share RapidPlan models that can improve the efficiency and quality of treatment models and cancer care across multiple institutions.
VAR: 94.60 (+0.14)

Varian Medical Systems Selected to Supply First Modern Radiotherapy Systems in Ethiopia
PR Newswire - Mon Aug 01, 7:00AM CDT
Cancer patients in Ethiopia will gain access to modern radiotherapy treatments for the first time with the announcement that Varian Medical Systems (NYSE: VAR) has been selected to supply advanced medical linear accelerators to six hospitals in the country. The Clinac(TM) iX treatment systems will be the first such devices offering treatments to cancer patients in a country of more than 90 million people.
VAR: 94.60 (+0.14), MDSY: 1.47 (unch)

Watch for Varian Medical Systems to Potentially Pullback After Gaining 6.22% Yesterday
Comtex SmarTrend(R) - Thu Jul 28, 1:01PM CDT
Varian Medical Systems (NYSE:VAR) traded in a range yesterday that spanned from a low of $90.10 to a high of $94.16. Yesterday, the shares gained 6.2%, which took the trading range above the 3-day high of $88.91 on volume of 1.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
VAR: 94.60 (+0.14)

Varian Medical (VAR) Beats Q3 Earnings & Sales; View Up
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 10:15AM CDT
Varian Medical Systems Inc. (VAR) reported earnings of $1.22 per share in the third quarter of fiscal 2016, which beat the Zacks Consensus Estimate by a nickel.
BABY: 38.41 (-0.04), ABMD: 118.79 (-0.12), MASI: 52.64 (+0.10), VAR: 94.60 (+0.14)

Varian Chosen to Equip First Government Owned Proton Center in China
PR Newswire - Wed Jul 27, 3:15PM CDT
Varian Medical Systems (NYSE: VAR), today announced it has been selected to install and service its ProBeam® proton therapy system in the new multi-room Hefei Ion Medical Center (HIMC) being built in Hefei, Anhui Province, China. The company booked the order for the equipment as well as its ARIA® information management and Eclipse(TM) treatment planning software in the third quarter of its fiscal year 2016.
VAR: 94.60 (+0.14)

Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2016
PR Newswire - Wed Jul 27, 3:05PM CDT
Varian Medical Systems (NYSE: VAR) today is reporting GAAP net earnings of $1.04 per diluted share and non-GAAP net earnings of $1.22 per diluted share for the third quarter of fiscal year 2016. Varian's revenues totaled $789 million for the third quarter, up 1 percent from the year-ago quarter in dollars and even with the year-ago quarter in constant currency. The company ended the quarter with a $3.3 billion backlog, up 5 percent from the end of the third quarter of fiscal year 2015.
VAR: 94.60 (+0.14)

Varian Medical: Claymount Collimators Get FDA Registration
Zacks Equity Research - Zacks Investment Research - Tue Jul 19, 7:31AM CDT
Varian Medical Systems, Inc. recently received the U.S. Food and Drug Administration (FDA) registration for its Claymount Optica 20 and Optica 40 collimators.
MASI: 52.64 (+0.10), VAR: 94.60 (+0.14), MLAB: 105.11 (-3.16), NVDQ: 10.64 (+0.06)

Varian Medical Systems Receives FDA Registration for Claymount Optica Collimators
PR Newswire - Mon Jul 18, 7:15AM CDT
Varian Medical Systems (NYSE: VAR) today announced it has received U.S. Food and Drug Administration (FDA) registration for its Claymount Optica 20 and Optica 40 collimators. Claymount's Optica collimators are used to narrow the focus of X-ray beams in film-based and digital radiography systems for improving image quality and minimizing dose to patients.
VAR: 94.60 (+0.14)

What Investors are Making of These Medical Appliances and Equipment Stocks? - St. Jude Medical, ResMed, Steris, and Varian Medical Systems
PR Newswire - Thu Jul 07, 6:40AM CDT
Stock-Callers.com's focus this morning is on the Medical Appliances and Equipment industry, which can expect strong growth for the remainder of this year despite headwinds. We look at the featured companies for today and review their recent performances: St. Jude Medical Inc. (NYSE: STJ), ResMed Inc. (NYSE: RMD), Steris PLC (NYSE: STE), and Varian Medical Systems Inc. (NYSE: VAR). Learn more about these stocks and receive your complimentary notes at:
VAR: 94.60 (+0.14), STE: 70.48 (-0.28), RMD: 68.88 (-0.50), STJ: 83.50 (-0.02), MDSY: 1.47 (unch)

Varian Medical Systems (VAR) Approaches New Upside Target of $82.48
Comtex SmarTrend(R) - Tue Jun 21, 8:46AM CDT
Varian Medical Systems (NYSE:VAR) has opened bullishly above the pivot of $81.83 today and has reached the first level of resistance at $82.07. Analysts will be watching for a cross of the next upside pivot targets of $82.48 and $83.13.
VAR: 94.60 (+0.14)

Varian Medical Systems Holding Investor Meeting Today
PR Newswire - Tue Jun 21, 7:00AM CDT
Varian Medical Systems (NYSE: VAR) announced it is hosting an investor day at its headquarters in Palo Alto, Calif., today, Tuesday, June 21. The company's corporate and business management will discuss global growth strategies in its Oncology Systems, Imaging Components and Particle Therapy businesses. Presentations will focus on emerging technologies, product portfolios, and market trends that will support the expansion of Varian's businesses.
VAR: 94.60 (+0.14)

Varian Medical Systems Launches Proton Therapy Blog
PR Newswire - Mon Jun 20, 7:15AM CDT
Varian Medical Systems (NYSE: VAR), today announced the launch of Spot ON, a company blog about proton therapy for the treatment of cancer. Targeted at clinicians, physicists and administrators of radiotherapy centers around the world, Spot ON will deliver information about new technology developments, system deployments, research and insights from clinicians.
VAR: 94.60 (+0.14)

Varian Medical Clinches TrueBeam System Order in Australia
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 6:47AM CDT
Varian Medical Systems Inc. (VAR) won order from Australia-based Icon Group to supply 10 additional TrueBeam medical linear accelerators.
IRMD: 17.22 (+0.15), MASI: 52.64 (+0.10), VAR: 94.60 (+0.14), CRY: 14.13 (-0.12)

Icon Group in Australia Selects Varian Advanced Radiotherapy Equipment
PR Newswire - Thu Jun 16, 7:15AM CDT
Varian Medical Systems (NYSE: VAR), today announced it has been selected by the Icon Group to provide 10 TrueBeam® medical linear accelerators for cancer centers Icon operates across Australia. Varian will install the TrueBeam systems in the Icon centers over the next two years and continue to service them under a multi-year agreement.
VAR: 94.60 (+0.14)

Varian and Russian Proton Therapy Center Achieve Milestone with Cyclotron Installation
PR Newswire - Thu Jun 09, 7:00AM CDT
Russia's first dedicated proton therapy treatment center achieved a major milestone this week with the installation of the cyclotron by equipment supplier Varian Medical Systems (NYSE: VAR). The installation, a key milestone for each new proton therapy center, involved the cyclotron being lifted into position by cranes in a procedure that was watched by local government officials including the governor of St. Petersburg.
VAR: 94.60 (+0.14)

Varian Keeps Up the Winning Streak in Turkey, Expands Base
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 7:39AM CDT
Varian Medical Systems Inc (VAR) is on a roll, winning a string of orders in Turkey.
IRMD: 17.22 (+0.15), MASI: 52.64 (+0.10), VAR: 94.60 (+0.14), CRY: 14.13 (-0.12)

Varian to Showcase Imaging Solutions At 19th World Conference On Non-destructive Testing
PR Newswire - Wed Jun 08, 7:15AM CDT
Varian Medical Systems (NYSE: VAR), today announced plans to demonstrate its security and industrial imaging solutions June 13-17 in Munich Germany at the 19th World Conference on Non-destructive Testing (WCNDT), booth FE73.
VAR: 94.60 (+0.14), MDSY: 1.47 (unch)

Varian Extending Advanced Cancer Care in Turkey
PR Newswire - Tue Jun 07, 7:00AM CDT
Cancer patients in Turkey will gain access to advanced radiotherapy treatments with news that Varian Medical Systems (NYSE: VAR), world leader in radiotherapy and radiosurgery, has been selected to supply multiple treatment machines to public and private hospitals in the country. To date this year, Varian has booked orders for more than 20 medical linear accelerators from Turkish hospitals. The new systems will be delivered over the next 18 months.
VAR: 94.60 (+0.14), MDSY: 1.47 (unch)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MiniCo's New Desk: A Game Changer for E&S Market

Updated Category News Views 2

A New Chapter in Industrial Casualty Look out, folks! MiniCo Insurance Agency is making waves with its latest launch. They're teaming up with Lloyd's of London, not to sell fish and chips, but to bring something groundbreaking in the insurance space—an industrial casualty trading desk. And if you’re raising an eyebrow wondering why this matters, let me break it down...

Continue Reading
Haystack MRD Shines in Colorectal Cancer Trials

Updated Category News Views 3

A New Dawn in Cancer Detection Just when you think you've seen it all in cancer diagnostics, Haystack MRD® pops up like a fresh tulip in spring. And listen, this ain't just fluff—the results from the DYNAMIC trials are a pretty compelling love letter to the power of liquid biopsy. With 100% specificity and sensitivity hitting a whopping 83.3% over five years, it’s...

Continue Reading
Local Expertise in Real Estate: Key to Success?

Updated Category News Views 5

Local Market Know-How: A Seller's Best Asset So you're thinking about selling your home in North Carolina, huh? Here's a tip—get yourself a local real estate pro who knows the ins and outs of your neighborhood like the back of their hand. Michael McCollum, a prominent voice from Reidsville, NC, highlights how crucial local expertise can be in navigating the widely...

Continue Reading
EPR Fireworks, Schedule2.IT Enhance EMS Integration

Updated Category News Views 6

Joining Forces for Effective EMS Management In a move that could shake up emergency medical services, EPR Fireworks has teamed up with Schedule2.IT to amp up integration. This Florida-based partnership is all about breaking down those bureaucratic firewalls between patient care and controlled substances tracking. They’re pushing for a seamless workflow, where crucial...

Continue Reading
OSHA and NSC Forge Alliance to Prevent Worksite Tragedies

Updated Category News Views 4

Forging Ahead With a Crucial Collaboration Ins, outs, ups, and downs—safety shouldn’t get lost in the shuffle, but it does. In steps the National Serious Injury and Fatality Prevention Alliance, a fresh partnership convened by OSHA with the National Safety Council—hop on board or get left behind mindsets. We’re talking about real, heads-down, hard-hitting actions...

Continue Reading
Ultrabench Revolutionizes AI Model Comparison Game

Updated Category News Views 2

Breaking Down the Messy AI Model Landscape Ultrabench.ai is here to drag AI model comparison out of the dark ages. Picture this: 309 AI models, ranked against a whopping 530 benchmarks, all served up on one plate. If you’re navigating the AI jungle, you’ll realize how Ultrabench is no small fish in this vast ocean. Consolidating Where Others Have Scattered There's a...

Continue Reading
Concrete Pipe: Foundation of Modern Infrastructure

Updated Category News Views 5

Reinforced Concrete Pipes Hold Their Ground You know, it might not be the flashiest part of our infrastructure toolkit, but concrete pipe plays a mighty big role behind the scenes. Even in this age of shiny new tech and constantly evolving materials, the classic concrete pipe still packs a punch—especially when you demand something that'll last. Enter Stephanie Ward, a...

Continue Reading
Hyundai's Record Q3 Sales: SUVs and Hybrids Lead

Updated Category News Views 2

Hyundai's Drive to Record Q3 Sales When talking about market moves, Hyundai's recent figures speak louder than most quarterly bells. September 2026 marked a whirlwind of growth for Hyundai Motor America, reporting record-breaking sales numbers not just for the month, but for Q3 as a whole. With a 9% jump from September last year in total vehicle sales and a remarkable 3%...

Continue Reading
Vortex Expands UK Reach with Torrent Acquisition Boost

Updated Category News Views 5

Vortex's Ambitious UK Expansion A seasoned investor keen on infrastructure plays would find Vortex Companies’ latest move significant—not just another acquisition, but a realigned strategy for dominance as Britain braces for an infrastructure overhaul. With Torrent Drainage Services in their pocket, the Vortex Group plans to amp up its trenchless rehabilitation...

Continue Reading
Comparent Unveils Key Insights with Top 100 List

Updated Category News Views 4

The Ebb and Flow of Vacation Rental Giants Ever noticed how some industries just sneak up and suddenly transform landscapes? Vacation rental management is one of those sneaky offenders. At the forefront of keeping tabs on this bustling sector, Comparent just dropped a meaty second annual roster—the Comparent 100—showcasing the biggest players flexing their muscles in...

Continue Reading

Top 5 Most Recently Viewed Articles

Sage Therapeutics Faces Legal Action Over Securities Violations

Updated Category News Views 107

Class Action Lawsuit Filed Against Sage Therapeutics Sage Therapeutics, Inc. is currently facing a class action lawsuit that raises serious concerns for its investors. This legal challenge centers on alleged violations of the Securities Exchange Act, which could have significant consequences for those who own shares in the company. Key Information for Investors If you...

Continue Reading
Celebrating Exceptional Volunteers: Junior Achievement Honors 12

Updated Category News Views 250

Celebrating the Volunteers of Junior Achievement Junior Achievement of USA (JA) has recently announced its selection of 12 remarkable volunteers for the prestigious JA Gold Leadership Award. These individuals have been chosen from a remarkable pool of over 150,000 volunteers nationwide. This award is a testament to their dedication and exceptional commitment to enhancing...

Continue Reading
Anju Showcases Revolutionary MA Knowledge at DIA MICC 2024

Updated Category News Views 310

Explore Anju's Innovative MA Knowledge at DIA MICC 2024 Anju, a leader in the life sciences software industry, is excited to showcase its offerings at the upcoming DIA Medical Information & Communications Conference. This important event, aimed at professionals working with medical information, is just around the corner. What to Look Forward to with MA Knowledge At the...

Continue Reading
The Oncology Institute Earnings Release and Growth Insights

Updated Category News Views 124

The Oncology Institute Shares Upcoming Earnings Release Plans In a significant announcement, The Oncology Institute, Inc. (NASDAQ: TOI) revealed its strategy for releasing first quarter financial results. This gathering is especially crucial for stakeholders and interested parties within the oncology sector. Earnings Release and Conference Call Details The financial...

Continue Reading
Centogene's Extraordinary Meeting Marks Key Company Decisions

Updated Category News Views 203

Exciting Developments from Centogene's Extraordinary General Meeting Centogene N.V. (OTC: CNTGF) has recently celebrated a notable progress point in the company’s journey during its remarkable Extraordinary General Meeting. With a significant representation of 57.16% of the Company’s issued share capital, shareholders rallied behind all proposed resolutions. Most...

Continue Reading